Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

New technologies and industry collaboration will help fight chronic illnesses

March 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, pharma

Authored by Dan Boot, Head of Digital Innovation at RB Health.Around the world, populations are aging. According to the World …
Feature

European Commission offers €80m to CureVac to develop coronavirus vaccine

March 17, 2020 Manufacturing and Production, Research and Development, Sales and Marketing CureVac, EU, US, coronavirus

Following confirmation of reports that US President Donald Trump sought to persuade a biotech to provide US-exclusivity for a potential …
News

FDA gives emergency authorisation to first coronavirus tests

March 17, 2020 Manufacturing and Production, Sales and Marketing FDA, Roche, US, coronavirus

The coronavirus crisis in the US has thus far been characterised by a lack of testing within its population. This …
News

Genmab announces newly-created Chief Financial Officer appointment

March 16, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genmab, pharma

Genmab has announced the establishment of the new position of Chief Operating Officer at the company, and has furthermore named …
Appointment

Trump tried to solicit US-exclusivity for coronavirus vaccine, report claims

March 16, 2020 Sales and Marketing CureVac, Trump, US, coronavirus, pharma

President Trump has attracted criticism from all sides over his response to the novel coronavirus outbreak; after repeatedly downplaying the …
News

Bavencio Phase 3 head and neck cancer trial terminated

March 16, 2020 Research and Development, Sales and Marketing Bavencio, Cancer, EMD Serono, Merck KGaA, Pfizer, trial failure

Merck KGaA, its biopharma division EMD Serono, and Pfizer have announced their decision to terminate their ongoing Phase 3 trial …
News

NHS England to supply HIV prevention drug PrEP with £16m government investment

March 16, 2020 Manufacturing and Production, Sales and Marketing NHS, NHS England, PrEP HIV, PrEP< HIV, UK, pharma

NHS England is set to fund the availability of pre-exposure prophylaxis (PrEP) for the prevention of HIV for local authorities …
News

Fosun and BioNTech partner up for coronavirus vaccine development and commercialisation

March 16, 2020 Research and Development, Sales and Marketing BioNTech, coronavirus, fosun, pharma

As the novel coronavirus (COVID-19) outbreak continues to test global leadership, a new partnership has been announced between BioNTech and …
News

FDA greenlights Celltrion HIV drug manufacturing facility in South Korea

March 16, 2020 Manufacturing and Production, Sales and Marketing FDA, celltrion, coronavirus, pharma

South Korean biopharma firm Celltrion has revealed that one of its key manufacturing facilities has been given the all-clear by …
News

Top Ten most popular articles on Pharmafile.com this week

March 13, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Coronavirus Wuhan, HIV, HIV/AIDS, UK Coronavirus, coronavirus

HIV treatment featured heavily in the news this week, as Uganda is preparing to enter the final stages of developing …
News

Venclyxto combo scores European approval for previously untreated chronic lymphocytic leukaemia

March 13, 2020 Medical Communications, Sales and Marketing AbbVie, European Commission, Roche, Venclyxto, pharma

The European Commission has moved to authorise AbbVie and Roche’s B-cell lymphoma-2 (BCL-2) inhibitor Venclyxto (venetoclax) when used in combination …
News

Keytruda rejected for NHS use for bladder cancer, will be removed from the Cancer Drugs Fund

March 12, 2020 Sales and Marketing Cancer, Kidney cancer, MSD, NHS, NICE, blader cancer, keytruda, pharma

MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) has been knocked back by NICE for use on the NHS as a treatment for …
News

Teva’s Ajovy becomes first drug of its kind available on NHS for prevention of chronic migraine

March 12, 2020 Sales and Marketing NICE, Teva, ajovy, migraine, pharma

NICE has announced the authorisation of Teva’s anti-CGRP drug Ajovy (fremanezumab) for the prevention of chronic migraine in adult patients …
News

FDA halts overseas inspections over coronavirus concerns

March 11, 2020 Research and Development, Sales and Marketing FDA, US, approvals, pharma

The FDA has responded to the ongoing COVID-19 coronavirus outbreak by announcing that it will halt all inspections of overseas …
News

Takeda’s Ninlaro combo fails to hit main goal in newly diagnosed, transplant ineligible multiple myeloma

March 11, 2020 Research and Development, Sales and Marketing Ninlaro, Takeda, multiple myeloma, pharma

Takeda has unveiled new Phase 3 data for its oral proteasome inhibitor Ninlaro (ixazomib) in the treatment of newly diagnosed …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026